Literature DB >> 3495270

Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion.

J N Chacon, M R Chedekel, E J Land, T G Truscott.   

Abstract

Various unstable intermediate oxidation states have been postulated in the metabolic activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl pyridinium ion. We now report the first direct observation of these free radical intermediates by pulse radiolysis and flash photolysis. Studies are described of various reactions of such species, in particular with dopamine whose autoxidation to dopamine quinone is reported to be potentiated by 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495270     DOI: 10.1016/s0006-291x(87)80057-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Brain oxidative stress as basic target of antioxidant traditional oriental medicines.

Authors:  Tetsuya Konishi
Journal:  Neurochem Res       Date:  2008-11-06       Impact factor: 3.996

Review 2.  Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.

Authors:  Pamela Lopert; Manisha Patel
Journal:  J Neural Transm (Vienna)       Date:  2015-03-07       Impact factor: 3.575

Review 3.  Semicarbazide-sensitive amine oxidase (SSAO) in the brain.

Authors:  Toshio Obata
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.